| Type | Title | Author(s) | Year | Views |
| Tailored Selection of Nucleic Acid Aptamers against Sclerostin and Aggrecanase for Skeletal Disease Therapeutics | Yu, Y; Chan, WL; Shum, KT; Tanner, JA | 2012 | 63 |
| |
| Investigation of the protein/polyphosphate binding interface: mutational studies on mycobacterium tuberculosis polyphosphate kinase 2 (PPK2) | Ao, KL; Shum, KT; Tanner, JA | 2012 | 58 |
| |
| Dissecting the mechanism of binding between polyphosphate and polyphosphate kinase 2 | Ao, KL; Shum, KT; Tanner, JA | 2012 | 71 |
| |
| G-quadruplex DNA aptamers and their ligands: Structure, function and application | Tucker, WO; Shum, KT; Tanner, JA | 2012 | 192 |
| |
| High-Affinity Nucleic Acid Aptamers against Sclerostin Protein | Tanner, JA; Shum, KT; Chan, SLC | 2011 | 133 |
| |
| DNA aptamers binding H5N1 virus nucleoprotein showed antiviral effects. | Zheng, B; Lin, Y; Shum, KT; Tanner, JA | 2011 | 103 |
| |
| Inhibiting sclerostin with a nucleic acid aptamer as a new approach to osteoporosis therapy | Shum, KT; Chan, SLC; Tanner, JA | 2011 | 105 |
| |
| Aptamer-mediated inhibition of mycobacterium tuberculosis polyphosphate kinase 2 | Shum, KT; Lui, ELH; Wong, SCK; Yeung, P; Sam, L; Wang, Y; Watt, RM; Tanner, JA | 2011 | 212 |
| |
| Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling | Shum, KT; Chan, C; Leung, CM; Tanner, JA | 2011 | 201 |
| |
| Study of DNA aptamers binding H5N1 virus nucleoprotein | Lin, Y; Shum, KT; Tanner, JA; Zheng, B | 2010 | 1,139 |
| |
| Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2 | Shum, KT; Lui, ELH; Wang, Y; Watt, RM; Tanner, JA | 2010 | 127 |
| |
| New approaches to osteoporosis therapy with aptamer-based inhibitors | Shum, KT; Tucker, WO; Chan, SLC; Leung, CM; Tanner, JA | 2010 | 100 |
| |
| Chemical biology | Tanner, JA; Shum, KT | 2010 | 124 |
| |
| Effect of Inorganic Polyphosphate on Higher Eukaryotic Cells | Lui, LHE; Shum, KT; Tanner, JA | 2009 | 81 |
| |
| Aptamers against polyphosphate kinase 2 (PPK2) from mycobacterium tuberculosis as a potential approach of novel anti-tuberculosis therapy | Lui, ELH; Shum, KT; Sam, L; Wang, Y; Watt, RM; Tanner, JA | 2009 | 153 |
| |
| Aptamer-based Inhibitor of Sclerostin for Osteoporosis Therapy | Shum, KT; Chan, C; Leung, CM; Tanner, JA | 2009 | 96 |
| |
| Selection, validation and delivery of DNA aptamers against infectious disease targets | Tanner, JA; Zheng, B; Lin, YP; Kimura, M; Lui, ELH; Shum, KT | 2009 | 138 |
| |
| G-quadruplex aptamers inhibit sclerostin for osteoporosis therapy | Shum, KT; Chan, CSL; Leung, CM; Tanner, JA | 2009 | 298 |
| |
| Aptamer-mediated Inhibition of Mycobacterium tuberculosis Polyphosphate Kinase 2 | Shum, KT; Tanner, JA | 2009 | 98 |
| |
| Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. | Shum, KT; Tanner, JA | 2008 | 104 |
| |
